Bradley Merrill Thompson Comments on FTC Charges Against Medical App Developer’s Advertising Claims – Media Coverage Roundup

Multiple Publications

Bradley Merrill Thompson, Member of the Firm in the Health Care and Life Sciences practice, in the Washington, DC, office, was quoted in multiple publications regarding a recent FTC complaint against an app developer, charging that its app advertising made unsubstantiated claims of medical benefit.

Following is an excerpt from Reuters:

"We could well see FTC taking the primary enforcement role," said Bradley Merrill Thompson, a Washington D.C.-based attorney with the firm Epstein Becker & Green. That the FTC took action, rather than the U.S. Food and Drug Administration, represents an important shift, Thompson added.

Related links:

MedCity News, 01/21/2015

mHealth News, 01/21/2015

HealthData Management, 01/21/2015

Politico, 01/21/2015

Reuters, 01/20/2015

MobiHealth News, 01/20/2015